Skip to main content
Top
Published in: Journal of Hematology & Oncology 1/2008

Open Access 01-12-2008 | Research

Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.

Authors: Majid Khalaf, Hani Abdel-Nabi, John Baker, Yiping Shao, Dominick Lamonica, Jayakumari Gona

Published in: Journal of Hematology & Oncology | Issue 1/2008

Login to get access

Abstract

Abstract

The most common semiquantitative method of evaluation of pulmonary lesions using 18F-FDG PET is FDG standardized uptake value (SUV). An SUV cutoff of 2.5 or greater has been used to differentiate between benign and malignant nodules. The goal of our study was to investigate the correlation between the size of pulmonary nodules and the SUV for benign as well as for malignant nodules.

Methods

Retrospectively, 173 patients were selected from 420 referrals for evaluation of pulmonary lesions. All patients selected had a positive CT and PET scans and histopathology biopsy. A linear regression equation was fitted to a scatter plot of size and SUVmax for malignant and benign nodules together. A dot diagram was created to calculate the sensitivity, specificity, and accuracy using an SUVmax cutoff of 2.5.

Results

The linear regression equations and (R2)s as well as the trendlines for malignant and benign nodules demonstrated that the slope of the regression line is greater for malignant than for benign nodules. Twenty-eight nodules of group one (≤ 1.0 cm) are plotted in a dot diagram using an SUVmax cutoff of 2.5. The sensitivity, specificity, and accuracy were calculated to be 85%, 36% and 54% respectively. Similarly, sensitivity, specificity, and accuracy were calculated for an SUVmax cutoff of 2.5 and found to be 91%, 47%, and 79% respectively for group 2 (1.1–2.0 cm); 94%, 23%, and 76%, respectively for group 3 (2.1–3.0 cm); and 100%, 17%, and 82%,, respectively for group 4 (> 3.0 cm). The previous results of the dot diagram indicating that the sensitivity and the accuracy of the test using an SUVmax cutoff of 2.5 are increased with an increase in the diameter of pulmonary nodules.

Conclusion

The slope of the regression line is greater for malignant than for benign nodules. Although, the SUVmax cutoff of 2.5 is a useful tool in the evaluation of large pulmonary nodules (> 1.0 cm), it has no or minimal value in the evaluation of small pulmonary nodules (≤ 1.0 cm).
Appendix
Available only for authorised users
Literature
1.
go back to reference Lowe V, Hoffman J, DeLong D, Patz E, Coleman E: Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994, 35: 1771-1776.PubMed Lowe V, Hoffman J, DeLong D, Patz E, Coleman E: Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994, 35: 1771-1776.PubMed
2.
go back to reference Thie J: Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004, 45: 1431-1434.PubMed Thie J: Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004, 45: 1431-1434.PubMed
3.
go back to reference Lee KS, Kim Y, Han J, Ko EJ, Park CK, Primack SL: Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. RadioGraphics. 1997, 17: 1345-1357.CrossRefPubMed Lee KS, Kim Y, Han J, Ko EJ, Park CK, Primack SL: Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. RadioGraphics. 1997, 17: 1345-1357.CrossRefPubMed
4.
go back to reference Heyneman LE, Patz EF: PET imaging in patients with bronchioloalveolar cellcarcinoma. Lung Cancer. 2002, 38: 261-266. 10.1016/S0169-5002(02)00221-0.CrossRefPubMed Heyneman LE, Patz EF: PET imaging in patients with bronchioloalveolar cellcarcinoma. Lung Cancer. 2002, 38: 261-266. 10.1016/S0169-5002(02)00221-0.CrossRefPubMed
5.
go back to reference Erasmus JJ, McAdams HP, Patz EF, Coleman RE, Ahuja V, Goodman PC: Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18-F-fluorodeoxyglucose. AJR. 1998, 170: 1369-1373.CrossRefPubMed Erasmus JJ, McAdams HP, Patz EF, Coleman RE, Ahuja V, Goodman PC: Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18-F-fluorodeoxyglucose. AJR. 1998, 170: 1369-1373.CrossRefPubMed
6.
go back to reference Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N: Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18 fluorodeoxyglucose uptake. J Nucl Med. 1994, 35: 104-112.PubMed Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N: Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18 fluorodeoxyglucose uptake. J Nucl Med. 1994, 35: 104-112.PubMed
7.
go back to reference Ollenberger G, Knight S, Tauro A: False-positive FDG positron emission tomography in pulmonary amyloidosis. Clin Nucl Med. 2004, 29: 657-658. 10.1097/00003072-200410000-00018.CrossRefPubMed Ollenberger G, Knight S, Tauro A: False-positive FDG positron emission tomography in pulmonary amyloidosis. Clin Nucl Med. 2004, 29: 657-658. 10.1097/00003072-200410000-00018.CrossRefPubMed
8.
go back to reference Shin L, Katz D, Yung E: Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med. 2004, 29: 654-656. 10.1097/00003072-200410000-00017.CrossRefPubMed Shin L, Katz D, Yung E: Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med. 2004, 29: 654-656. 10.1097/00003072-200410000-00017.CrossRefPubMed
9.
go back to reference Herder G, Golding R, Hoekstra O: The performance of 18F fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2004, 31: 1231-1236. 10.1007/s00259-004-1552-7.CrossRefPubMed Herder G, Golding R, Hoekstra O: The performance of 18F fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2004, 31: 1231-1236. 10.1007/s00259-004-1552-7.CrossRefPubMed
10.
go back to reference Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K: Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004, 45: 19-27. 10.1016/j.lungcan.2004.01.009.CrossRefPubMed Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K: Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004, 45: 19-27. 10.1016/j.lungcan.2004.01.009.CrossRefPubMed
11.
go back to reference Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K: Visual and semiquantitative analysis for F-18 FDG PET scanning in pulmonary nodules 1 cm to 3 cm in size. An thoracic surg. 2005, 79: 984-988. 10.1016/j.athoracsur.2004.07.072.CrossRef Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K: Visual and semiquantitative analysis for F-18 FDG PET scanning in pulmonary nodules 1 cm to 3 cm in size. An thoracic surg. 2005, 79: 984-988. 10.1016/j.athoracsur.2004.07.072.CrossRef
12.
go back to reference Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K: Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med. 2006, 47 (3): 426-431.PubMed Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K: Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med. 2006, 47 (3): 426-431.PubMed
13.
go back to reference Kim S, Allen-Auerbach M, Goldin J, Fueger B, Dahlbom M, Brown M, Czernin J, Schiepers C: Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007, 48 (2): 214-220.PubMed Kim S, Allen-Auerbach M, Goldin J, Fueger B, Dahlbom M, Brown M, Czernin J, Schiepers C: Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007, 48 (2): 214-220.PubMed
14.
go back to reference Townsend D, Carney J, Yap J, Hall N: PET/CT: Today and Tomorrow. J Nucl Med. 2004, 45: 4S-14S.PubMed Townsend D, Carney J, Yap J, Hall N: PET/CT: Today and Tomorrow. J Nucl Med. 2004, 45: 4S-14S.PubMed
15.
go back to reference Quon A, Napel S, Beaulieu C, Gambhir S: Novel 3D rendered FDG PET/CT virtual bronchoscopy and colonography for improved lesion localization and presurgical evaluation [abstract]. J Nucl Med. 2005, 46 (suppl): 108P-109P. Quon A, Napel S, Beaulieu C, Gambhir S: Novel 3D rendered FDG PET/CT virtual bronchoscopy and colonography for improved lesion localization and presurgical evaluation [abstract]. J Nucl Med. 2005, 46 (suppl): 108P-109P.
16.
go back to reference Buck AK, Hetzel M, Schirrmeister H, Halter G, Möller P, Kratochwil C, Wahl A, Glatting G, Mottaghy FM, Mattfeldt T, Neumaier B, Reske SN: Clinical relevance of imaging proliferative activity in lung nodules. Eur J Nucl Med Mol Imaging. 2005, 32: 525-533. 10.1007/s00259-004-1706-7.CrossRefPubMed Buck AK, Hetzel M, Schirrmeister H, Halter G, Möller P, Kratochwil C, Wahl A, Glatting G, Mottaghy FM, Mattfeldt T, Neumaier B, Reske SN: Clinical relevance of imaging proliferative activity in lung nodules. Eur J Nucl Med Mol Imaging. 2005, 32: 525-533. 10.1007/s00259-004-1706-7.CrossRefPubMed
17.
go back to reference Cobben DC, Elsinga PH, Hoekstra HJ, Suurmeijer AJ, Vaalburg W, Maas B, Jager PL, Groen HM: Is 18 F-3'-Fluoro-3'-deoxy-L thymidine useful for the staging and restaging of non-small cell lung cancer?. J Nucl Med. 2004, 45: 1677-1682.PubMed Cobben DC, Elsinga PH, Hoekstra HJ, Suurmeijer AJ, Vaalburg W, Maas B, Jager PL, Groen HM: Is 18 F-3'-Fluoro-3'-deoxy-L thymidine useful for the staging and restaging of non-small cell lung cancer?. J Nucl Med. 2004, 45: 1677-1682.PubMed
18.
go back to reference Tian M, Zhang H, Higuchi T, Oriuchi N, Endo K: Oncological diagnosis using (11)C-choline-positron emission tomography in comparison with 2-deoxy-2-[(18)F] fluoro-D-glucose-positron emission tomography. Mol Imaging Biol. 2004, 6 (3): 172-179. 10.1016/j.mibio.2004.02.003.CrossRefPubMed Tian M, Zhang H, Higuchi T, Oriuchi N, Endo K: Oncological diagnosis using (11)C-choline-positron emission tomography in comparison with 2-deoxy-2-[(18)F] fluoro-D-glucose-positron emission tomography. Mol Imaging Biol. 2004, 6 (3): 172-179. 10.1016/j.mibio.2004.02.003.CrossRefPubMed
Metadata
Title
Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
Authors
Majid Khalaf
Hani Abdel-Nabi
John Baker
Yiping Shao
Dominick Lamonica
Jayakumari Gona
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2008
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-1-13

Other articles of this Issue 1/2008

Journal of Hematology & Oncology 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine